Speaker

Mamatha Bhat, M.D.

Toronto General Hospital
Mamatha Bhat, M.D.

Biography

Dr. Mamatha Bhat is a Hepatologist and leads the Transplant AI initiative at the University Health Network's Ajmera Transplant Centre, and Associate Professor of Medicine at the University of Toronto. Dr. Bhat completed her medical school and residency training at McGill University. She then completed a Transplant Hepatology fellowship at the Mayo Clinic in Rochester, Minnesota, followed by a Canadian Institutes of Health Research (CIHR) Fellowship for Health Professionals, through which she completed a PhD.
The goal of Dr. Bhat's research program is to improve long-term outcomes of liver transplantation through a precision medicine approach. Her program is unique in using tools of Artificial Intelligence with bioinformatics to personalize the care of liver transplant recipients based on an improved biological understanding of the liver and disease after transplant. Her interdisciplinary program has been supported by the Canadian Institutes for Health Research (CIHR), Canadian Donation and Transplant Research Program (CDTRP), Natural Sciences and Engineering Research Council (NSERC), Canadian Liver Foundation (CLF), among others. Dr. Bhat is Partnership & Engagement Lead for the Temerty Centre for AI Research and Education in Medicine (T-CAIREM), Chair of the International Liver Transplant Society Basic and Translational Science Research committee; on the Executive committee of the CDTRP, and an Associate Editor for the American Journal of Transplantation. Dr. Bhat has also been the recipient of recognitions such as the 2022 CIHR-INMD-CASL Early Career Researcher prize, CASL Research Excellence award and the 2021 American Society of Transplantation Basic Science Career Development Award.

Sessions

7:00 AM - 7:45 AM
Nov 08 2025
Washington, D.C.

MTE #6 Artificial Intelligence in Pediatric Hepatology and Pediatric Liver Transplantation (Ticketed)

Hepatitis
Basic Science
ALD
DEI
MASLD
Liver Cancer
Pediatrics
Acute Liver Failure
Trainee
Hepatology Associates
Acute-on-Chronic Liver Failure
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Transplant
8:00 AM - 9:30 AM
Nov 09 2025
Washington, D.C.

Basic Science Workshop, Ribonucleic Acid Nanomedicine: Reprogramming Cells to Transform Liver Outcomes, Part 1—Cutting-Edge Tools for Liver Gene Editing

Batuhan Orbay Yenilmez, PhD , Presenter
Marshall S Padilla , Presenter
Valerie VG Gouon-Evans, PharmD, PhD , Presenter
Hepatitis
Basic Science
ALD
DEI
MASLD
Liver Cancer
Pediatrics
Acute Liver Failure
Trainee
Hepatology Associates
Acute-on-Chronic Liver Failure
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Transplant
11:00 AM - 12:30 PM
Nov 09 2025
Washington, D.C.

Basic Science Workshop, Ribonucleic Acid Nanomedicine: Reprogramming Cells to Transform Liver Outcomes, Part 2—Transforming Chronic Liver Disease: Breakthroughs and Clinical Updates in Ribonucleic Acid Nanotherapeutics   

Mamatha Bhat, M.D. , Presenter
Gen-Sheng Feng, PhD , Presenter
Satdarshan P Monga, MD, FAASLD , Presenter
Rohit Loomba, MD, MHSc, FAASLD , Presenter
Hepatitis
Basic Science
ALD
DEI
MASLD
Liver Cancer
Pediatrics
Acute Liver Failure
Trainee
Hepatology Associates
Acute-on-Chronic Liver Failure
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Transplant
3:45 PM - 4:45 PM
Nov 10 2025
Washington, D.C.

Tech and Tweets: Navigating the Future of Hepatology in a Digital World

Atoosa Rabiee, MD, MD , Presenter
Elliot B. Tapper, MD, FAASLD , Presenter
Alexandra T Strauss, MD, PhD, MIE , Presenter
Hepatitis
Basic Science
ALD
DEI
MASLD
Liver Cancer
Pediatrics
Acute Liver Failure
Trainee
Hepatology Associates
Acute-on-Chronic Liver Failure
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Transplant